Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chongguang Chen

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
European Journal of Pharmacology|January 20, 2004
Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptorChongguang Chen, Jin Li, George Bot, et al.
The Journal of Biological Chemistry|November 13, 2008
GEC1-kappa opioid receptor binding involves hydrophobic interactions: GEC1 has chaperone-like effectYong Chen, Chongguang Chen, Evangelia Kotsikorou, et al.
Neuropharmacology|September 25, 2020
Pharmacological and phosphoproteomic approaches to roles of protein kinase C in kappa opioid receptor-mediated effects in miceJeffrey J Liu, Yi-Ting Chiu, Chongguang Chen, et al.
Life Sciences|April 30, 2013
PKA and ERK1/2 are involved in dopamine D₁ receptor-induced heterologous desensitization of the δ opioid receptorWei Xu, Chongguang Chen, Jian-Guo Li, et al.
The Biochemical Journal|December 5, 2015
Determination of sites of U50,488H-promoted phosphorylation of the mouse κ opioid receptor (KOPR): disconnect between KOPR phosphorylation and internalizationChongguang Chen, Yi-Ting Chiu, Wenman Wu, et al.
Biochemical Pharmacology|December 5, 2006
Cholesterol reduction by methyl-beta-cyclodextrin attenuates the delta opioid receptor-mediated signaling in neuronal cells but enhances it in non-neuronal cellsPeng Huang, Wei Xu, Su-In Yoon, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2006
Localization of the kappa opioid receptor in lipid raftsWei Xu, Su-In Yoon, Peng Huang, et al.
Brain Research|November 6, 2007
Agonist treatment did not affect association of mu opioid receptors with lipid rafts and cholesterol reduction had opposite effects on the receptor-mediated signaling in rat brain and CHO cellsPeng Huang, Wei Xu, Su-In Yoon, et al.
Frontiers in Pharmacology|October 14, 2022
Reactivation of cocaine contextual memory engages mechanistic target of rapamycin/S6 kinase 1 signalingXiangdang Shi, Eva von Weltin, Emma Fitzsimmons, et al.
ACS Chemical Neuroscience|September 8, 2020
Comparison of Pharmacological Properties between the Kappa Opioid Receptor Agonist Nalfurafine and 42B, Its 3-Dehydroxy Analogue: Disconnect between <i>in Vitro</i> Agonist Bias and <i>in Vivo</i> Pharmacological EffectsDanni Cao, Peng Huang, Yi-Ting Chiu, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
European Journal of Pharmacology|January 20, 2004
Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptorChongguang Chen, Jin Li, George Bot, et al.
The Journal of Biological Chemistry|November 13, 2008
GEC1-kappa opioid receptor binding involves hydrophobic interactions: GEC1 has chaperone-like effectYong Chen, Chongguang Chen, Evangelia Kotsikorou, et al.
Neuropharmacology|September 25, 2020
Pharmacological and phosphoproteomic approaches to roles of protein kinase C in kappa opioid receptor-mediated effects in miceJeffrey J Liu, Yi-Ting Chiu, Chongguang Chen, et al.
Life Sciences|April 30, 2013
PKA and ERK1/2 are involved in dopamine D₁ receptor-induced heterologous desensitization of the δ opioid receptorWei Xu, Chongguang Chen, Jian-Guo Li, et al.
The Biochemical Journal|December 5, 2015
Determination of sites of U50,488H-promoted phosphorylation of the mouse κ opioid receptor (KOPR): disconnect between KOPR phosphorylation and internalizationChongguang Chen, Yi-Ting Chiu, Wenman Wu, et al.
Biochemical Pharmacology|December 5, 2006
Cholesterol reduction by methyl-beta-cyclodextrin attenuates the delta opioid receptor-mediated signaling in neuronal cells but enhances it in non-neuronal cellsPeng Huang, Wei Xu, Su-In Yoon, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2006
Localization of the kappa opioid receptor in lipid raftsWei Xu, Su-In Yoon, Peng Huang, et al.
Brain Research|November 6, 2007
Agonist treatment did not affect association of mu opioid receptors with lipid rafts and cholesterol reduction had opposite effects on the receptor-mediated signaling in rat brain and CHO cellsPeng Huang, Wei Xu, Su-In Yoon, et al.
Frontiers in Pharmacology|October 14, 2022
Reactivation of cocaine contextual memory engages mechanistic target of rapamycin/S6 kinase 1 signalingXiangdang Shi, Eva von Weltin, Emma Fitzsimmons, et al.
ACS Chemical Neuroscience|September 8, 2020
Comparison of Pharmacological Properties between the Kappa Opioid Receptor Agonist Nalfurafine and 42B, Its 3-Dehydroxy Analogue: Disconnect between <i>in Vitro</i> Agonist Bias and <i>in Vivo</i> Pharmacological EffectsDanni Cao, Peng Huang, Yi-Ting Chiu, et al.
Pageof 5